Instruction for use: Etadex-MEZ

Dosage form: ophthalmic solution

Active substance: Hydroxyaethylaminoadeninum

ATX

S01XA Eye contraceptives

Pharmacological groups

Regenerants and reparants

Ophthalmic products

The nosological classification (ICD-10)

H16 Keratitis: Adenoviral keratitis; Bacterial keratitis; Spring keratitis; Deep keratitis without epithelial lesion; Deep keratitis without epithelial damage; discoid keratitis; Outline keratitis; keratitis rosacea; Keratitis with corneal destruction; Superficial keratitis; punctate keratitis; Traumatic keratitis; Superficial punctate keratitis

H16.0 Corneal ulcer: Allergic corneal ulcer; Allergic corneal ulcer; Erosion of the cornea; Regional ulcer; Purulent corneal ulcer; Corneal ulcer; Trophic ulcers of the cornea; Traumatic erosion of the cornea; Ulceration of the cornea; Keratitis with corneal ulceration; Ulcerative keratitis; Purulent corneal ulcers; Epithelial point keratitis; Ulceration of superficial corneal layers; Keratomalacia; Corneal ulcer; Recurrent erosions of the cornea; Recurrent ulcers of the cornea; Bacterial corneal ulcer; Septic ulcer of the cornea; Corneal edge ulcer

H16.2 Keratoconjunctivitis: Chronic allergic keratoconjunctivitis; Bacterial keratoconjunctivitis; Deep forms of adenovirus keratoconjunctivitis; Infectious conjunctivitis and keratoconjunctivitis caused by Chlamydia trachomatis; Acute allergic keratoconjunctivitis; Spring keratoconjunctivitis; Phlyctenular keratoconjunctivitis

H18.4 Corneal degeneration: corneal infiltrate; Secondary corneal dystrophy; The destruction of the cornea; corneal Dystrophy; Keratitis with corneal destruction; Violation of corneal trophism; Violation of the integrity of the cornea; Violation of the integrity of the corneal epithelium; Primary corneal dystrophy; Degenerative corneal disease

S05.0 Injury of the conjunctiva and corneal abrasion without mention of the foreign body: Superficial injury of the cornea; Corneal surface damage; Traumatic erosion of the cornea; Mechanical injuries of the cornea

S05.8 Other eye and orbital injuries (broken eye): Corneal damage

T30 Thermal and chemical burns of unspecified site: Pain syndrome with burns; Pain in burns; Pain with burns; Sluggishly healing post-burn wounds; Deep burns with a wet scab; Deep burns with abundant compartments; Deep burn; Laser burn; Burn; Burn of rectum and perineum; Burn with mild exudation; Burn disease; Burn injury; Superficial burn; Superficial burn of I and II degree; Superficial skin burns; After-burn trophic ulcer and wound; Post-burn complication; Loss of fluid in burns; Sepsis burn; Thermal burns; Thermal skin lesions; Thermal burn; Trophic after-burn ulcers; Chemical burn; Surgical burn

Composition and release form

1 ml eye drops contains 5 mg etaden, as well as auxiliary substances (polyglucin, sodium chloride, nipagin, nipase, purified water); In bottles of 5 ml with a lid-dropper, in a cardboard bundle 1 bottle or in tubes-droppers for 1.3 ml, in a cardboard bundle 2 tubes.

Characteristic

Stimulator of reparative cell regeneration.

Transparent or slightly opalescent, colorless or slightly colored liquid.

Pharmachologic effect

Mode of action - Regenerating.

Activates the biosynthesis and exchange of nucleic acids, has a pronounced regenerating effect on the corneal tissue. Polyglucinum provides prolongation of action.

Pharmacokinetics

With topical application, systemic absorption is low.

Indication of the drug Etadex-MEZ

Complex treatment of cornea diseases with violation of the integrity of the epithelium, ulceration and dystrophic changes (including thermal and chemical burns of the cornea, mechanical injuries of the cornea, including traumatic erosion, keratitis, dry keratoconjunctivitis, corneal dystrophy).

Contraindications

Hypersensitivity to the components of the drug.

Application of pregnancy and breastfeeding

Perhaps, if the expected effect of therapy exceeds the potential risk for the fetus and infant (sufficient experience in the use of the drug during pregnancy and lactation is not).

Side effects

Sensation of "foreign body" and short-term burning after instillation of the drug.

Interaction

With simultaneous administration of eye drops of the Etadex-MEZ and solutions of sodium salts of sulfonamides (sulfacil sodium), the recommended interval between instillations is at least 30 minutes.

Dosing and Administration

1-2 drops in the conjunctival sac 3 times a day; The course of treatment should not exceed 10 days.

Overdose

Accidental ingestion does not create a risk of unwanted side effects.

Precautionary measures

If there is no effect within 5 days, other methods of treatment should be used. The use of the drug in children is possible if the expected effect exceeds the risk of possible side effects (there is insufficient experience in using the drug in children).

Storage conditions of the drug Etadex-MEZ

At a temperature not higher than 20 ° C.

Keep out of the reach of children.

Shelf life of the drug Etadex-MEZ

2 years.

Do not use after the expiry date printed on the package.